{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:42:55Z","timestamp":1773967375123,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204761"],"award-info":[{"award-number":["82204761"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Deyang Science and Technology Bureau","award":["2024SZY120"],"award-info":[{"award-number":["2024SZY120"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04437-5","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T23:37:06Z","timestamp":1769816226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Research trends and hotspots of nanomaterials in Alzheimer's disease: bibliometric analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhao","family":"Ran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Lan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"10284","key":"4437_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390.","journal-title":"Lancet"},{"issue":"2","key":"4437_CR2","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"issue":"8003","key":"4437_CR3","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/d41586-024-00756-8","volume":"627","author":"E Landhuis","year":"2024","unstructured":"Landhuis E. Researchers call for a major rethink of how Alzheimer\u2019s treatments are evaluated. Nature. 2024;627(8003):S18-s20.","journal-title":"Nature"},{"issue":"6","key":"4437_CR4","first-page":"Cd001190","volume":"6","author":"JS Birks","year":"2018","unstructured":"Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2018;6(6):Cd001190.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"4437_CR5","first-page":"Cd003154","volume":"3","author":"R McShane","year":"2019","unstructured":"McShane R, et al. Memantine for dementia. Cochrane Database Syst Rev. 2019;3(3):Cd003154.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"4437_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"key":"4437_CR7","doi-asserted-by":"publisher","first-page":"1281338","DOI":"10.3389\/fnagi.2023.1281338","volume":"15","author":"H Barmaki","year":"2023","unstructured":"Barmaki H, Nourazarian A, Khaki-Khatibi F. Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1281338.","journal-title":"Front Aging Neurosci"},{"key":"4437_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","volume":"11","author":"WM Pardridge","year":"2019","unstructured":"Pardridge WM. Blood-brain barrier and delivery of protein and gene therapeutics to brain. Front Aging Neurosci. 2019;11:373.","journal-title":"Front Aging Neurosci"},{"issue":"7618","key":"4437_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"4","key":"4437_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"4437_CR11","doi-asserted-by":"publisher","first-page":"2003937","DOI":"10.1002\/advs.202003937","volume":"8","author":"W Zhang","year":"2021","unstructured":"Zhang W, et al. Development of polymeric nanoparticles for blood-brain barrier transfer-strategies and challenges. Adv Sci (Weinh). 2021;8(10):2003937.","journal-title":"Adv Sci (Weinh)"},{"issue":"24","key":"4437_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2174\/1381612828666220608093639","volume":"28","author":"M Farhoudi","year":"2022","unstructured":"Farhoudi M, et al. The therapeutic benefits of intravenously administrated nanoparticles in stroke and age-related neurodegenerative diseases. Curr Pharm Des. 2022;28(24):1985\u20132000.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"4437_CR13","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1021\/acsami.1c17861","volume":"14","author":"K Ge","year":"2022","unstructured":"Ge K, et al. Gold nanorods with spatial separation of CeO(2) deposition for plasmonic-enhanced antioxidant stress and photothermal therapy of Alzheimer\u2019s disease. ACS Appl Mater Interfaces. 2022;14(3):3662\u201374.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4437_CR14","doi-asserted-by":"publisher","first-page":"123403","DOI":"10.1016\/j.biomaterials.2025.123403","volume":"322","author":"B Du","year":"2025","unstructured":"Du B, et al. Multi-targeted engineered hybrid exosomes as A\u03b2 nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer\u2019s disease. Biomaterials. 2025;322:123403.","journal-title":"Biomaterials"},{"key":"4437_CR15","doi-asserted-by":"publisher","first-page":"111360","DOI":"10.1016\/j.biopha.2021.111360","volume":"137","author":"Y Xu","year":"2021","unstructured":"Xu Y, et al. The application of multifunctional nanomaterials in Alzheimer\u2019s disease: a potential theranostics strategy. Biomed Pharmacother. 2021;137:111360.","journal-title":"Biomed Pharmacother"},{"key":"4437_CR16","doi-asserted-by":"publisher","first-page":"156410","DOI":"10.1016\/j.phymed.2025.156410","volume":"138","author":"X Shi","year":"2025","unstructured":"Shi X, Yin H, Shi X. Bibliometric analysis of literature on natural medicines against chronic kidney disease from 2001 to 2024. Phytomedicine. 2025;138:156410.","journal-title":"Phytomedicine"},{"issue":"1","key":"4437_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12987-025-00659-4","volume":"22","author":"RJ Boado","year":"2025","unstructured":"Boado RJ, Bickel U, Sumbria RK. The legacy of William M. Pardridge (1947\u20132024) on the science and fields concerned with the physiology of the blood-brain barrier and the transport of drugs to the brain. Fluids Barriers CNS. 2025;22(1):46.","journal-title":"Fluids Barriers CNS"},{"key":"4437_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061283","author":"WM Pardridge","year":"2022","unstructured":"Pardridge WM. A historical review of brain drug delivery. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14061283.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4437_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17425247.2020.1698544","volume":"17","author":"G Tosi","year":"2020","unstructured":"Tosi G, Duskey JT, Kreuter J. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opin Drug Deliv. 2020;17(1):23\u201332.","journal-title":"Expert Opin Drug Deliv"},{"key":"4437_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev. 2014;71:2\u201314.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"4437_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1021\/acsbiomaterials.8b01334","volume":"5","author":"JT Yang","year":"2019","unstructured":"Yang JT, et al. Protection against neurodegeneration in the Hippocampus using sialic acid- and 5-HT-moduline-conjugated lipopolymer nanoparticles. ACS Biomater Sci Eng. 2019;5(3):1311\u201320.","journal-title":"ACS Biomater Sci Eng"},{"key":"4437_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.msec.2018.05.062","volume":"91","author":"YC Kuo","year":"2018","unstructured":"Kuo YC, Tsai HC. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect \u03b2-amyloid-insulted neurons. Mater Sci Eng C Mater Biol Appl. 2018;91:445\u201357.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"4437_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, et al. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34\u201347.","journal-title":"J Control Release"},{"issue":"2","key":"4437_CR24","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","volume":"10","author":"HJ Kwon","year":"2016","unstructured":"Kwon HJ, et al. Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease. ACS Nano. 2016;10(2):2860\u201370.","journal-title":"ACS Nano"},{"issue":"5580","key":"4437_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"issue":"23","key":"4437_CR26","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/smll.201201068","volume":"8","author":"YH Liao","year":"2012","unstructured":"Liao YH, et al. Negatively charged gold nanoparticles inhibit Alzheimer\u2019s amyloid-\u03b2 fibrillization, induce fibril dissociation, and mitigate neurotoxicity. Small. 2012;8(23):3631\u20139.","journal-title":"Small"},{"issue":"46","key":"4437_CR27","doi-asserted-by":"publisher","first-page":"15437","DOI":"10.1021\/ja8041806","volume":"130","author":"C Cabaleiro-Lago","year":"2008","unstructured":"Cabaleiro-Lago C, et al. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc. 2008;130(46):15437\u201343.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"4437_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","volume":"35","author":"C Zhang","year":"2014","unstructured":"Zhang C, et al. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer\u2019s disease mice. Biomaterials. 2014;35(1):456\u201365.","journal-title":"Biomaterials"},{"issue":"5","key":"4437_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, et al. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20(5):362\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"4437_CR30","doi-asserted-by":"publisher","first-page":"1542607","DOI":"10.3389\/fnagi.2025.1542607","volume":"17","author":"ZY Tian","year":"2025","unstructured":"Tian ZY, et al. Alzheimer\u2019s disease and insomnia: a bibliometric study and visualization analysis. Front Aging Neurosci. 2025;17:1542607.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4437_CR31","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12951-024-02907-5","volume":"22","author":"Z Feng","year":"2024","unstructured":"Feng Z, et al. Nanozymes: a bibliometrics review. J Nanobiotechnology. 2024;22(1):704.","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"4437_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101\u201324.","journal-title":"Nat Rev Drug Discov"},{"key":"4437_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245789","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R. Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25245789.","journal-title":"Molecules"},{"issue":"3","key":"4437_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"4437_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7031","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, et al. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/sciadv.abc7031.","journal-title":"Sci Adv"},{"issue":"12","key":"4437_CR36","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1021\/acs.accounts.3c00045","volume":"56","author":"R Limbocker","year":"2023","unstructured":"Limbocker R, et al. Characterization of pairs of toxic and nontoxic misfolded protein oligomers elucidates the structural determinants of oligomer toxicity in protein misfolding diseases. Acc Chem Res. 2023;56(12):1395\u2013405.","journal-title":"Acc Chem Res"},{"issue":"43","key":"4437_CR37","doi-asserted-by":"publisher","first-page":"12818","DOI":"10.1039\/D2SC02654F","volume":"13","author":"Z Yu","year":"2022","unstructured":"Yu Z, et al. Amphiphilic stilbene derivatives attenuate the neurotoxicity of soluble A\u03b2(42) oligomers by controlling their interactions with cell membranes. Chem Sci. 2022;13(43):12818\u201330.","journal-title":"Chem Sci"},{"issue":"34","key":"4437_CR38","doi-asserted-by":"publisher","first-page":"30347","DOI":"10.1021\/acsomega.2c03616","volume":"7","author":"M Gharb","year":"2022","unstructured":"Gharb M, et al. Inhibition of tau protein aggregation by a chaperone-like \u03b2-boswellic acid conjugated to gold nanoparticles. ACS Omega. 2022;7(34):30347\u201358.","journal-title":"ACS Omega"},{"key":"4437_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010196","author":"U Shabbir","year":"2020","unstructured":"Shabbir U, et al. Curcumin and its derivatives as theranostic agents in Alzheimer\u2019s disease: the implication of nanotechnology. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010196.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"4437_CR40","doi-asserted-by":"publisher","first-page":"e2307081","DOI":"10.1002\/adma.202307081","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Customized intranasal hydrogel delivering methylene blue ameliorates cognitive dysfunction against Alzheimer\u2019s disease. Adv Mater. 2024;36(19):e2307081.","journal-title":"Adv Mater"},{"issue":"6","key":"4437_CR41","doi-asserted-by":"publisher","first-page":"e2408581","DOI":"10.1002\/smll.202408581","volume":"21","author":"W Qian","year":"2025","unstructured":"Qian W, et al. The mitochondria-targeted micelle inhibits Alzheimer\u2019s disease progression by alleviating neuronal mitochondrial dysfunction and neuroinflammation. Small. 2025;21(6):e2408581.","journal-title":"Small"},{"issue":"3","key":"4437_CR42","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.3c09311","volume":"18","author":"S Wang","year":"2024","unstructured":"Wang S, et al. High-performance plasma biomarker panel for Alzheimer\u2019s disease screening using a femtomolar-level label-free biosensing system. ACS Nano. 2024;18(3):2117\u201330.","journal-title":"ACS Nano"},{"issue":"4","key":"4437_CR43","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1021\/acsabm.3c01201","volume":"7","author":"FS Vajedi","year":"2024","unstructured":"Vajedi FS, et al. Ultrasensitive aptasensing platform for the detection of \u03b2-amyloid-42 peptide based on MOF containing bimetallic porphyrin graphene oxide and gold nanoparticles. ACS Appl Bio Mater. 2024;7(4):2218\u201339.","journal-title":"ACS Appl Bio Mater"},{"key":"4437_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejpb.2018.06.011","volume":"129","author":"L Salade","year":"2018","unstructured":"Salade L, et al. Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery. Eur J Pharm Biopharm. 2018;129:257\u201366.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"4437_CR45","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/acschemneuro.4c00839","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. Determinants for substoichiometric inhibition of IAPP and A\u03b2 amyloid aggregations by Bri2 BRICHOS. ACS Chem Neurosci. 2025;16(6):1150\u201360.","journal-title":"ACS Chem Neurosci"},{"key":"4437_CR46","doi-asserted-by":"publisher","first-page":"8169","DOI":"10.2147\/IJN.S435472","volume":"18","author":"P Jara-Guajardo","year":"2023","unstructured":"Jara-Guajardo P, et al. Differential detection of amyloid aggregates in old animals using gold nanorods by computerized tomography: a pharmacokinetic and bioaccumulation study. Int J Nanomed. 2023;18:8169\u201385.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4437_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.apsb.2019.11.003","volume":"10","author":"C Xiang","year":"2020","unstructured":"Xiang C, et al. Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication. Acta Pharm Sin B. 2020;10(2):239\u201348.","journal-title":"Acta Pharm Sin B"},{"key":"4437_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081183","author":"MK Satapathy","year":"2021","unstructured":"Satapathy MK, et al. Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13081183.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4437_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12951-025-03109-3","volume":"23","author":"YJ Jang","year":"2025","unstructured":"Jang YJ, et al. Drug delivery strategies with lipid-based nanoparticles for Alzheimer\u2019s disease treatment. J Nanobiotechnology. 2025;23(1):99.","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"4437_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11095-020-02865-1","volume":"37","author":"RGR Pinheiro","year":"2020","unstructured":"Pinheiro RGR, et al. RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer\u2019s disease. Pharm Res. 2020;37(7):139.","journal-title":"Pharm Res"},{"key":"4437_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010038","author":"GR Topal","year":"2020","unstructured":"Topal GR, et al. ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood-brain barrier. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics13010038.","journal-title":"Pharmaceutics"},{"issue":"40","key":"4437_CR52","doi-asserted-by":"publisher","first-page":"e2207626","DOI":"10.1002\/smll.202207626","volume":"19","author":"F Mohebichamkhorami","year":"2023","unstructured":"Mohebichamkhorami F, et al. Microfluidic synthesis of ultrasmall chitosan\/graphene quantum dots particles for intranasal delivery in Alzheimer\u2019s disease treatment. Small. 2023;19(40):e2207626.","journal-title":"Small"},{"issue":"3","key":"4437_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/08982104.2021.2019763","volume":"32","author":"S Salehi","year":"2022","unstructured":"Salehi S, et al. Chitosan-coated niosome as an efficient curcumin carrier to cross the blood-brain barrier: an animal study. J Liposome Res. 2022;32(3):284\u201392.","journal-title":"J Liposome Res"},{"key":"4437_CR54","doi-asserted-by":"publisher","first-page":"120714","DOI":"10.1016\/j.carbpol.2023.120714","volume":"310","author":"L Yang","year":"2023","unstructured":"Yang L, et al. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer\u2019s disease. Carbohydr Polym. 2023;310:120714.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"4437_CR55","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41565-023-01551-8","volume":"19","author":"J Gao","year":"2024","unstructured":"Gao J, et al. Intracerebral fate of organic and inorganic nanoparticles is dependent on microglial extracellular vesicle function. Nat Nanotechnol. 2024;19(3):376\u201386.","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"4437_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1248\/yakushi.19-00187-5","volume":"140","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Ishima Y, Ishida T. Induction of anti-PEG immune responses by PEGylation of proteins. Yakugaku Zasshi. 2020;140(2):163\u20139.","journal-title":"Yakugaku Zasshi"},{"key":"4437_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020276","author":"MC Operti","year":"2022","unstructured":"Operti MC, et al. Industrial scale manufacturing and downstream processing of PLGA-based nanomedicines suitable for fully continuous operation. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14020276.","journal-title":"Pharmaceutics"},{"key":"4437_CR58","doi-asserted-by":"publisher","first-page":"102291","DOI":"10.1016\/j.arr.2024.102291","volume":"97","author":"AK Roghani","year":"2024","unstructured":"Roghani AK, et al. Treating Alzheimer\u2019s disease using nanoparticle-mediated drug delivery strategies\/systems. Ageing Res Rev. 2024;97:102291.","journal-title":"Ageing Res Rev"},{"key":"4437_CR59","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Ahmad R, Khare SK. Alzheimer\u2019s disease and its treatment by different approaches: a review. Eur J Med Chem. 2021;216:113320.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"4437_CR60","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11019-025-10272-9","volume":"28","author":"K Korecky","year":"2025","unstructured":"Korecky K, Schicktanz S. Unresolved ethical questions of mHealth apps for Alzheimer\u2019s disease prevention. Med Health Care Philos. 2025;28(3):473\u201385.","journal-title":"Med Health Care Philos"},{"key":"4437_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/polym17050558","author":"MG Dabija","year":"2025","unstructured":"Dabija MG, et al. Chitosan as a plurivalent biopolymer in nanodelivery systems. Polymers. 2025. https:\/\/doi.org\/10.3390\/polym17050558.","journal-title":"Polymers"},{"issue":"1","key":"4437_CR62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12951-025-03561-1","volume":"23","author":"F Huang","year":"2025","unstructured":"Huang F, et al. Early-life exposure to polypropylene nanoplastics induces neurodevelopmental toxicity in mice and human iPSC-derived cerebral organoids. J Nanobiotechnology. 2025;23(1):474.","journal-title":"J Nanobiotechnology"},{"key":"4437_CR63","doi-asserted-by":"publisher","first-page":"113429","DOI":"10.1016\/j.ecoenv.2022.113429","volume":"235","author":"M Li","year":"2022","unstructured":"Li M, et al. Advanced human developmental toxicity and teratogenicity assessment using human organoid models. Ecotoxicol Environ Saf. 2022;235:113429.","journal-title":"Ecotoxicol Environ Saf"},{"key":"4437_CR64","doi-asserted-by":"publisher","first-page":"157815","DOI":"10.1016\/j.scitotenv.2022.157815","volume":"849","author":"X Liu","year":"2022","unstructured":"Liu X, et al. The uses of transcriptomics and lipidomics indicated that direct contact with graphene oxide altered lipid homeostasis through ER stress in 3D human brain organoids. Sci Total Environ. 2022;849:157815.","journal-title":"Sci Total Environ"},{"issue":"3","key":"4437_CR65","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1021\/acs.langmuir.0c03039","volume":"37","author":"T Terada","year":"2021","unstructured":"Terada T, et al. Characterization of lipid nanoparticles containing ionizable cationic lipids using design-of-experiments approach. Langmuir. 2021;37(3):1120\u20138.","journal-title":"Langmuir"},{"issue":"3","key":"4437_CR66","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/09205063.2023.2287247","volume":"35","author":"M Kouhjani","year":"2024","unstructured":"Kouhjani M, et al. Microfluidic-assisted preparation of PLGA nanoparticles loaded with insulin: a comparison with double emulsion solvent evaporation method. J Biomater Sci Polym Ed. 2024;35(3):306\u201329.","journal-title":"J Biomater Sci Polym Ed"},{"key":"4437_CR67","doi-asserted-by":"publisher","first-page":"111940","DOI":"10.1016\/j.biopha.2021.111940","volume":"141","author":"T Waghule","year":"2021","unstructured":"Waghule T, et al. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): a risk based industrial approach. Biomed Pharmacother. 2021;141:111940.","journal-title":"Biomed Pharmacother"},{"key":"4437_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071419","author":"RM Almuqbil","year":"2022","unstructured":"Almuqbil RM, Sreeharsha N, Nair AB. Formulation-by-design of efinaconazole spanlastic nanovesicles for transungual delivery using statistical risk management and multivariate analytical techniques. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071419.","journal-title":"Pharmaceutics"},{"issue":"11","key":"4437_CR69","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.drudis.2021.06.016","volume":"26","author":"M Rahman","year":"2021","unstructured":"Rahman M, et al. Three \u2019D\u2019s: Design approach, dimensional printing, and drug delivery systems as promising tools in healthcare applications. Drug Discov Today. 2021;26(11):2726\u201333.","journal-title":"Drug Discov Today"},{"issue":"11","key":"4437_CR70","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1111\/jgs.18599","volume":"71","author":"J Gabbard","year":"2023","unstructured":"Gabbard J, et al. Career development in pragmatic clinical trials to improve care for people living with dementia. J Am Geriatr Soc. 2023;71(11):3554\u201365.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"4437_CR71","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/JCMA.0000000000001252","volume":"88","author":"CK Wu","year":"2025","unstructured":"Wu CK, Fuh JL. A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum. J Chin Med Assoc. 2025;88(7):495\u2013502.","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"4437_CR72","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jrsm.1729","volume":"15","author":"M Gusenbauer","year":"2024","unstructured":"Gusenbauer M. Beyond Google scholar, Scopus, and Web of Science: an evaluation of the backward and forward citation coverage of 59 databases\u2019 citation indices. Res Synth Methods. 2024;15(5):802\u201317.","journal-title":"Res Synth Methods"},{"issue":"1","key":"4437_CR73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12874-020-01010-1","volume":"20","author":"AA Ayorinde","year":"2020","unstructured":"Ayorinde AA, et al. Publication and related biases in health services research: a systematic review of empirical evidence. BMC Med Res Methodol. 2020;20(1):137.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"4437_CR74","doi-asserted-by":"publisher","first-page":"103688","DOI":"10.1016\/j.autrev.2024.103688","volume":"23","author":"H Bai","year":"2024","unstructured":"Bai H, Tian J. Refining search and keyword strategies in autoimmune ear disease bibliometric studies. Autoimmun Rev. 2024;23(12):103688.","journal-title":"Autoimmun Rev"},{"key":"4437_CR75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jconrel.2022.10.023","volume":"352","author":"Z Pei","year":"2022","unstructured":"Pei Z, et al. Current perspectives and trend of nanomedicine in cancer: a review and bibliometric analysis. J Control Release. 2022;352:211\u201341.","journal-title":"J Control Release"},{"key":"4437_CR76","doi-asserted-by":"publisher","first-page":"972357","DOI":"10.3389\/fonc.2022.972357","volume":"12","author":"JX Tu","year":"2022","unstructured":"Tu JX, et al. Global research trends of artificial intelligence applied in esophageal carcinoma: a bibliometric analysis (2000\u20132022) via CiteSpace and VOSviewer. Front Oncol. 2022;12:972357.","journal-title":"Front Oncol"},{"issue":"12","key":"4437_CR77","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/jdd.13350","volume":"87","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. A bibliometric comparison of undergraduate and postgraduate endodontic education publications: the topics, trends, and challenges. J Dent Educ. 2023;87(12):1661\u201375.","journal-title":"J Dent Educ"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04437-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04437-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04437-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:02:16Z","timestamp":1769821336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04437-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4437"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04437-5","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"20"}}